ETC
JANX icon

Exchange Traded Concepts’s Janux Therapeutics JANX Stock Holding History

Exchange Traded Concepts’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,043
Closed -$109K – 1463
2025
Q1 		$109K Buy
4,043
+686
+20% +$25.9K ﹤0.01% 1127
2024
Q4 		$180K Hold
3,357
– – ﹤0.01% 1014
2024
Q3 		$153K Sell
3,357
-2,397
-42% -$104K ﹤0.01% 1061
2024
Q2 		$241K Sell
5,754
-1,790
-24% -$84K 0.01% 850
2024
Q1 		$284K Sell
7,544
-6,660
-47% -$145K 0.01% 825
2023
Q4 		$152K Buy
14,204
+3,602
+34% +$31.1K ﹤0.01% 831
2023
Q3 		$107K Buy
10,602
+592
+6% +$6.83K ﹤0.01% 873
2023
Q2 		$119K Buy
+10,010
New +$134K ﹤0.01% 913

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return